Patients have saved Rs 12,447 crore due to fixation of prices of essential medicines by the government, Parliament was informed on Tuesday.
Out of the total savings, patients have saved Rs 2,422 crore under National List of Essential Medicines (NLEM) 2011 from May 2013 to February 2016, Minister for Chemicals and Fertilizers D V Sadananda Gowda said in a written reply to the Lok Sabha.
Further, a saving of Rs 2,644 crore was made under NLEM 2015 from March 2016 till date, he added.
Patients saved Rs 350 crore for cardio vascular and anti-diabetic medicines, Gowda said.
Due to fixing of prices of coronary stents and knee implants by the government, patients saved Rs 4,547 crore and Rs 1,500 crore, respectively, he added.
Moreover, patients have saved Rs 984 crore for anti-cancer drugs, Gowda said.
Highlighting the role of the National Pharmaceutical Pricing Authority (NPPA), Gowda said the Authority has taken important measures to check prices of drugs, under the Drugs (Prices Control) Order (DPCO).
Since inception of NPPA till May 2019, 2,033 demand notices have been issued to pharmaceutical companies for overcharging, he added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
